Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesisMatthew A. Loberg, Jennifer J. Trowbridge|Leukemia|2019Cited by 128
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCsMohsen Hosseini, Steven M. Chan, Samuele Ferrari et al.|Nature|2025Cited by 43
Challenges and opportunities for modeling aging and cancerOlga Anczuków, Karolina Palucka, Susie Airhart et al.|Cancer Cell|2023Cited by 24
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cellsLogan S. Schwartz, Jennifer J. Trowbridge|Experimental Hematology|2023Cited by 14
Metformin reduces the clonal fitness of Dnmt3aR878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateSteven M. Chan, Jennifer J. Trowbridge, Mohsen Hosseini et al.|Research Square|2024Cited by 5